MedTrace Logo

Thrombolysis Outcome in Ischemic Stroke

NCT04309357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 214

Last updated 2020-07-09

No results posted yet for this study

Summary

Consecutive patients with diagnosis of acute ischemic stroke and candidate of thrombolytic therapy during Jan 2017-Mar 2019 in BuAli Sina Hospital ,Sari, Iran, enrolled to this cohort study.

The demographic data, stroke characteristis, lab data and ... recorded. Then patients evaluate every 3 month until 12 month for fallow up.

Conditions

  • Stroke, Acute
  • Thrombolytic Therapy
  • Alteplase
  • Mortality

Interventions

DRUG

Alteplase

Alteplase in dose 0.9 mg/kg in acute ischemic patient with indications of thrombolytic therapy

Sponsors & Collaborators

  • Mazandaran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Sharifi-Razavi · Mazandaran University of Medical Science

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-04-30
Completion
2020-05-30
FDA Drug
Yes

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04309357 on ClinicalTrials.gov